These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30467994)

  • 41. Clinical characteristics, angiographic findings, and one-year outcome of 101 consecutive stent thrombosis cases in British Columbia.
    Lempereur M; Bogale N; Fahmy P; Shiekh I; Starovoytov A; Aymong E; Boone R; Robinson S; Charania J; Townley R; Thompson C; Kmetic A; Ding L; Fung A
    Cardiovasc Revasc Med; 2016 Mar; 17(2):74-80. PubMed ID: 26905061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and procedure characteristics in patients treated with polytetrafluoroethylene-covered stents after coronary perforation: a CIRC-8U multicenter registry and literature review.
    Itoh T; Kimura T; Kudo A; Morino Y; Ikari Y; Yoshioka K; Nakano M; Natsumeda M; Sakuma M; Inami S; Ako J; Nishinari M; Shimohama T; Komatsu T; Ishikawa T; Taguchi I; Sugimura H; Mitarai T; Akashi Y; Suzuki N; Sugi K; Matsumoto K; Kohshoh H; Yoshino H;
    Cardiovasc Interv Ther; 2021 Oct; 36(4):418-428. PubMed ID: 33037569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Covered stent implantation through a single 8-french guide catheter for the management of a distal coronary perforation.
    Sandoval Y; Lobo AS; Brilakis ES
    Catheter Cardiovasc Interv; 2017 Oct; 90(4):584-588. PubMed ID: 28303639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement.
    Stolker JM; Cohen DJ; Kennedy KF; Pencina MJ; Arnold SV; Kleiman NS; Spertus JA;
    Cardiovasc Revasc Med; 2017; 18(3):169-176. PubMed ID: 28041858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
    Onuma Y; Dudek D; Thuesen L; Webster M; Nieman K; Garcia-Garcia HM; Ormiston JA; Serruys PW
    JACC Cardiovasc Interv; 2013 Oct; 6(10):999-1009. PubMed ID: 24156961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 48. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
    Haude M; Lee SW; Worthley SG; Silber S; Verheye S; Erbs S; Rosli MA; Botelho R; Meredith I; Sim KH; Stella PR; Tan HC; Whitbourn R; Thambar S; Abizaid A; Koh TH; Den Heijer P; Parise H; Cristea E; Maehara A; Mehran R
    JACC Cardiovasc Interv; 2013 Apr; 6(4):334-43. PubMed ID: 23523459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Six-year clinical outcomes of first-generation drug-eluting stents: a propensity-matched analysis.
    Tarantini G; Barioli A; Facchin M; Frigo AC; Napodano M; Buja P; D'Amico G; Iliceto S; Isabella G
    Coron Artery Dis; 2013 Aug; 24(5):440-8. PubMed ID: 23695366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations.
    Ly H; Awaida JP; Lespérance J; Bilodeau L
    Am J Cardiol; 2005 Jan; 95(2):244-6. PubMed ID: 15642559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
    Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration.
    Giustino G; Mastoris I; Baber U; Sartori S; Stone GW; Leon MB; Serruys PW; Kastrati A; Windecker S; Valgimigli M; Dangas GD; Von Birgelen C; Smits PC; Kandzari D; Galatius S; Wijns W; Steg PG; Stefanini GG; Aquino M; Morice MC; Camenzind E; Weisz G; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Sep; 9(18):1890-901. PubMed ID: 27659564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence, predictors, management and outcomes of coronary perforations.
    Shaukat A; Tajti P; Sandoval Y; Stanberry L; Garberich R; Nicholas Burke M; Gössl M; Henry T; Mooney M; Sorajja P; Traverse J; Bradley SM; Brilakis ES
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):48-56. PubMed ID: 30312992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
    JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New coating stent design for patients with high-risk coronary lesions for thrombotic events: early and long-term results of the Camouflage registry.
    Perez G; Rodriguez-Granillo AM; Mieres J; Llaurado C; Rubilar B; Risau G; Fernandez-Pereira C; Rodriguez AE
    J Invasive Cardiol; 2009 Aug; 21(8):378-82. PubMed ID: 19652248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.